静脉、吸入或复合麻醉维持对儿童腺样体扁桃体切除术后呼吸不良事件的影响:AmPRAEC多中心随机临床试验
这项多中心随机临床试验纳入760例0-12岁接受腺样体扁桃体切除术的儿童,比较静脉麻醉维持(IV组)、静吸复合麻醉维持(IVIH组)和吸入麻醉维持(IH组)对术后麻醉恢复室呼吸不良事件(PRAE)发生率的影响。结果显示,IV组PRAE发生率最低(18.8%),IVIH组居中(28.5%),IH组最高(43.4%),且各组间风险差异显著。结论认为,丙泊酚静脉麻醉维持可逐步降低PRAE发生率,应考虑用于此类患儿。
要点
- 与吸入麻醉相比,静吸复合麻醉和纯静脉麻醉均显著降低患儿PRAE风险。
- 纯静脉麻醉(丙泊酚)的PRAE发生率最低,优于静吸复合麻醉。
- 接受腺样体扁桃体切除术的儿童可考虑采用丙泊酚静脉麻醉维持。
核心结论
- 丙泊酚静脉麻醉维持(单用或联合吸入麻醉)可逐步降低儿童腺样体扁桃体切除术后PRAE发生率。
- 建议对接受腺样体扁桃体切除术的儿童考虑采用丙泊酚静脉麻醉维持。
研究设计与样本
- 多中心随机临床试验(AmPRAEC研究),纳入中国12家医院的760例0-12岁接受腺样体扁桃体切除术的儿童。
- 随机分为静脉麻醉维持组(IV组)、静吸复合麻醉维持组(IVIH组)和吸入麻醉维持组(IH组)。
- 所有患儿均采用气管插管,且均清醒拔管;主要结局为麻醉恢复室PRAE发生率。
主要发现
- IV组PRAE发生率为18.8%(45/239),IVIH组为28.5%(70/246),IH组为43.4%(106/244)。
- 与IH组相比,IVIH组PRAE风险显著降低(aOR 0.44;95%CI 0.29-0.65;NNT=7)。
- IV组PRAE风险显著低于IVIH组(aOR 0.57;95%CI 0.36-0.90;NNT=6)。
- IV组PRAE风险显著低于IH组(aOR 0.25;95%CI 0.16-0.39;NNT=3)。
临床怎么用
- 对于接受腺样体扁桃体切除术的儿童,可优先选择丙泊酚静脉麻醉维持以降低PRAE风险。
- 若采用静吸复合麻醉,应知晓其PRAE风险仍高于纯静脉麻醉。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: General anesthetic drugs may affect the risk of postoperative respiratory adverse events (PRAEs) in children, but the effect of anesthesia maintenance strategies on these events has not yet been widely validated. This study tested the hypothesis that anesthesia maintenance with propofol infusion in addition to inhalation anesthesia or alone would lead to a progressive reduction in the incidence of PRAEs. METHODS: This multicenter randomized clinical trial (AmPRAEC study) enrolled 760 children aged 0 to 12 yr who underwent adenotonsillectomy at 12 hospitals in China. Patients were randomly assigned to the intravenous anesthesia maintenance (IV group), the combined intravenous-inhalation anesthesia maintenance (IVIH group), or the inhalation anesthesia maintenance (IH group). Tracheal tubes were used for airway management, with all children undergoing awake extubation. The primary outcome was PRAE incidence in the postanesthesia care unit. RESULTS: A total of 760 children (median [interquartile range] age, 6 [4 to 7] years; 460 boys [60.5%]) were randomized, and 729 total samples were available for modified intention-to-treat analysis. The IV group had the lowest incidence of PRAEs (45 of 239 [18.8%]), followed by the IVIH group (70 of 246 [28.5%]) and the IH group (106 of 244 [43.4%]). Compared to the IH group, the IVIH group had a significantly lower risk of PRAEs (adjusted odds ratio [aOR], 0.44; 95% confidence interval [CI], 0.29 to 0.65; number needed to treat, 7). The IV group had significantly lower risk compared to both the IVIH group (aOR, 0.57; 95% CI, 0.36 to 0.90; number needed to treat, 6) and the IH group (aOR, 0.25; 95% CI, 0.16 to 0.39; number needed to treat, 3). CONCLUSIONS: Anesthesia maintenance with propofol infusion in addition to inhalation anesthesia or alone resulted in a progressive reduction in the incidence of PRAEs. Propofol intravenous anesthesia maintenance should be considered for children undergoing adenotonsillectomy.
引用
- Shen F, Zhang L, Wang X, et al. Effect of Intravenous, Inhalational, or Combined Anesthesia Maintenance on Postoperative Respiratory Adverse Events in Children Undergoing Adenotonsillectomy (AmPRAEC): A Multicenter Randomized Clinical Trial. Anesthesiology. 2025. PMID: 40768554. doi:10.1097/ALN.0000000000005707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。